The article discusses the process of deprescribing, which involves stopping or reducing the use of inappropriate medications in older adults to minimize polypharmacy and improve patient outcomes. It outlines a five-step protocol for deprescribing, including identifying all current medications, assessing the risk of harm, evaluating the benefit-harm ratio of each medication, prioritizing medications for discontinuation, and implementing a discontinuation plan with close monitoring. The study highlights the importance of deprescribing due to the significant burden of adverse drug events, illness, disability, hospitalization, and even death caused by inappropriate polypharmacy in older adults. Evidence from randomized trials and observational studies supports the efficacy of deprescribing, with examples showing that discontinuing certain medications can reduce falls, improve cognitive and psychomotor function, and lower hospitalization rates. The article also addresses barriers to deprescribing, such as patient and prescriber concerns about adverse effects, and suggests strategies to facilitate deprescribing, including collaborative prescriber-pharmacist reviews and patient education. It emphasizes the need for a systematic approach to deprescribing in clinical practice, with a focus on patient-centered decision-making and shared responsibility between prescribers and pharmacists. The study concludes that deprescribing is feasible, safe, and beneficial, and calls for more research to define the circumstances under which deprescribing confers maximal benefit. The authors also highlight the importance of integrating deprescribing into quality use of medicines policies and practices to improve patient outcomes and reduce unnecessary suffering in older adults.The article discusses the process of deprescribing, which involves stopping or reducing the use of inappropriate medications in older adults to minimize polypharmacy and improve patient outcomes. It outlines a five-step protocol for deprescribing, including identifying all current medications, assessing the risk of harm, evaluating the benefit-harm ratio of each medication, prioritizing medications for discontinuation, and implementing a discontinuation plan with close monitoring. The study highlights the importance of deprescribing due to the significant burden of adverse drug events, illness, disability, hospitalization, and even death caused by inappropriate polypharmacy in older adults. Evidence from randomized trials and observational studies supports the efficacy of deprescribing, with examples showing that discontinuing certain medications can reduce falls, improve cognitive and psychomotor function, and lower hospitalization rates. The article also addresses barriers to deprescribing, such as patient and prescriber concerns about adverse effects, and suggests strategies to facilitate deprescribing, including collaborative prescriber-pharmacist reviews and patient education. It emphasizes the need for a systematic approach to deprescribing in clinical practice, with a focus on patient-centered decision-making and shared responsibility between prescribers and pharmacists. The study concludes that deprescribing is feasible, safe, and beneficial, and calls for more research to define the circumstances under which deprescribing confers maximal benefit. The authors also highlight the importance of integrating deprescribing into quality use of medicines policies and practices to improve patient outcomes and reduce unnecessary suffering in older adults.